Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide or Metolazone in Acute Heart Failure
NCT06273397Not yet recruiting
- Sponsor
- Clínica Alemana de Santiago
- Start
- May 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of acetazolamide and metolazone in acute heart failure (AHF) (3 arms), sponsored by Clínica Alemana de Santiago. Primary endpoint: Treatment success (Congestion Score 0-1) at 4 days. Planned start May 2024; status: not yet recruiting.
02
Drugs
acetazolamidemetolazone
03
Conditions
acute heart failure (AHF)
Beyond the preview
Go deeper on NCT06273397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06273397.